Alternatively, considering the complex relationship between the tumor cells and the microenvironment, the controversies of the outcome of Tks4 deregulation will likely be resolved by separate biological analysis of the lung cancer cells with different cancer stage background from various other components of the tumor microenvironment. The gene discussed is SH3PXD2B; the disease is lung carcinoma.